Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
Although the ability of coactivators to enhance the expression of estrogen receptor-alpha (ERalpha) target genes is well established, the role of corepressors in regulating 17beta-estradiol (E2)-induced gene expression is poorly understood. Previous studies revealed that the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full ERalpha transcriptional activity in MCF-7 breast cancer cells, and we report herein the E2-dependent recruitment of SMRT to the regulatory regions of the progesterone receptor (PR) and cyclin D1 genes. Individual depletion of SMRT or steroid receptor coactivator (SRC)-3 modestly decreased E2-induced PR and cyclin D1 expression; however, simultaneous depletion revealed a cooperative effect of this coactivator and corepressor on the expression of these genes. SMRT and SRC-3 bind directly in an ERalpha-independent manner, and this interaction promotes E2-dependent SRC-3 binding to ERalpha measured by co-IP and SRC-3 recruitment to the cyclin D1 gene as measured by chromatin IP assays. Moreover, SMRT stimulates the intrinsic transcriptional activity of all of the SRC family (p160) coactivators. Our data link the SMRT corepressor directly with SRC family coactivators in positive regulation of ERalpha-dependent gene expression and, taken with the positive correlation found for SMRT and SRC-3 in human breast tumors, suggest that SMRT can promote ERalpha- and SRC-3-dependent gene expression in breast cancer.
Karmakar
Sudipan
S
Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Gao
Tong
T
Pace
Margaret C
MC
Oesterreich
Steffi
S
Smith
Carolyn L
CL
D001943:Breast Neoplasms / Q000235:genetics; D045744:Cell Line, Tumor; D019938:Cyclin D1 / Q000235:genetics* / Q000378:metabolism; D004742:Enhancer Elements, Genetic / Q000235:genetics; D004958:Estradiol / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D056985:Nuclear Receptor Co-Repressor 2 / Q000737:chemistry / Q000172:deficiency / Q000378:metabolism*; D051958:Nuclear Receptor Coactivator 2 / Q000378:metabolism; D056921:Nuclear Receptor Coactivator 3 / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D017434:Protein Structure, Tertiary; D011980:Receptors, Progesterone / Q000235:genetics* / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D015533:Transcriptional Activation / Q000187:drug effects / Q000235:genetics
C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; C498001:NCOA2 protein, human; D056985:Nuclear Receptor Co-Repressor 2; D051958:Nuclear Receptor Coactivator 2; D011980:Receptors, Progesterone; D019938:Cyclin D1; D004958:Estradiol; D056921:Nuclear Receptor Coactivator 3
Mol Cell. 2004 Sep 24;15(6):937-49
15383283
Clin Cancer Res. 2007 Mar 1;13(5):1405-11
17332282
J Biol Chem. 1998 Oct 16;273(42):27645-53
9765300
Oncogene. 2008 Sep 25;27(43):5717-28
18542060
Int J Cancer. 2006 Feb 15;118(4):832-40
16152593
EMBO J. 2000 Aug 15;19(16):4342-50
10944117
Mol Cell Biol. 2005 Nov;25(21):9687-99
16227615
Mol Cell Biol. 2009 Feb;29(4):1017-34
19075001
Cell. 2004 Feb 20;116(4):511-26
14980219
EMBO J. 1996 Jul 15;15(14):3667-75
8670870
Mol Endocrinol. 2003 Jul;17(7):1296-314
12714702
Breast Cancer Res Treat. 2003 Mar;78(2):193-204
12725419
Science. 1999 Jun 25;284(5423):2174-7
10381882
Mol Endocrinol. 2010 Feb;24(2):346-58
19952285
Cancer Res. 2006 Nov 15;66(22):11039-46
17108143
Mol Endocrinol. 2002 Jul;16(7):1482-91
12089344
Mol Cell Biol. 2005 Jul;25(13):5552-66
15964811
J Biol Chem. 2000 Nov 17;275(46):35848-56
10960470
Cancer Res. 2009 Feb 1;69(3):958-66
19176386
Mol Cell Biol. 2007 Sep;27(17):5933-48
17591692
Mol Endocrinol. 1998 Oct;12(10):1605-18
9773983
Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6947-52
10359819
Biochemistry. 2007 Jul 10;46(27):8036-49
17571860
Mol Cell Biol. 2004 Jun;24(12):5157-71
15169882
J Biol Chem. 1995 Jun 9;270(23):13589-92
7539790
Biochem Biophys Res Commun. 2004 Mar 19;315(4):1070-6
14985122
Mol Cell. 2002 Mar;9(3):611-23
11931768
Cell. 1996 May 3;85(3):403-14
8616895
Mol Endocrinol. 1999 Dec;13(12):2108-21
10598585
Mol Cell. 2002 Nov;10(5):1019-32
12453411
Nat Genet. 2006 Nov;38(11):1289-97
17013392
Nature. 1995 Oct 5;377(6548):397-404
7566114
Breast Cancer Res Treat. 2009 May;115(1):77-85
18521745
Endocrinology. 2009 Apr;150(4):1588-96
19095746
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2920-5
9501191
Biol Reprod. 1996 Feb;54(2):287-93
8788178
J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):333-41
12361723
Endocr Rev. 2007 Aug;28(5):575-87
17609497
J Natl Cancer Inst. 2003 Mar 5;95(5):353-61
12618500
Science. 1995 Nov 24;270(5240):1354-7
7481822
EMBO J. 2004 Sep 15;23(18):3653-66
15343269
Clin Cancer Res. 1999 Nov;5(11):3460-7
10589759
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3519-24
10097068
FEBS Lett. 2000 Nov 24;485(2-3):195-9
11094166
Nature. 1995 Oct 5;377(6548):454-7
7566127
Mol Endocrinol. 1997 Jun;11(6):657-66
9171229
Mol Cell. 2000 Jun;5(6):939-48
10911988
J Biol Chem. 2001 Nov 16;276(46):42684-91
11553641
Cell. 1997 May 2;89(3):373-80
9150137
Genes Dev. 2000 May 1;14(9):1048-57
10809664
J Cell Sci. 2002 Feb 15;115(Pt 4):689-98
11865025
J Steroid Biochem Mol Biol. 2004 Aug;91(4-5):197-210
15336697
J Biol Chem. 2005 Feb 25;280(8):6511-9
15598662
Clin Cancer Res. 2003 Apr;9(4):1259-66
12684393
Annu Rev Physiol. 2005;67:309-33
15709961
Nature. 2008 Dec 4;456(7222):663-6
19005469
Nature. 1996 Sep 5;383(6595):99-103
8779723
Nature. 2009 Nov 5;462(7269):58-64
19890323
Mol Endocrinol. 2006 May;20(5):1048-60
16373395
Mol Cell. 2006 Jun 9;22(5):669-79
16762839
Cancer Res. 1988 Jan 15;48(2):246-53
2825969
Endocr Rev. 2004 Feb;25(1):45-71
14769827
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16701-6
12481024
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1339-44
15677324
Annu Rev Physiol. 2004;66:315-60
14977406
Endocr Rev. 1994 Jun;15(3):391-407
8076589
Science. 1997 Aug 15;277(5328):965-8
9252329
Breast Cancer Res Treat. 2001 Jul;68(1):21-8
11678305
Mol Cell Biol. 2008 Jun;28(11):3817-29
18362166
J Biol Chem. 2003 Feb 28;278(9):6912-20
12482846
Mol Cell. 2006 Feb 17;21(4):555-64
16483936
J Biol Chem. 2005 Mar 4;280(9):7493-503
15632172
Breast Cancer Res Treat. 2008 Aug;110(3):427-37
17902051
Mol Cell Biol. 2005 Jan;25(1):324-35
15601853
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1858-62
10051559
Cell. 2000 Dec 8;103(6):843-52
11136970
Mol Cell Biol. 1999 Feb;19(2):1182-9
9891052
Cancer Res. 2008 May 15;68(10):3697-706
18483252
Science. 2002 Mar 29;295(5564):2465-8
11923541
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8479-84
9238002
Genes Dev. 2006 Sep 15;20(18):2513-26
16980581